Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research focused on Brentuximab vedotin and Lymphoma, with related work in Oncology, Primary central nervous system lymphoma, Hodgkin lymphoma. Notable publications include 'Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma', 'Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted EPOCH ‐R', and 'Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT'.
Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT
Tumor-associated antigen–specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma
Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents
Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted <scp>EPOCH</scp>‐R